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The initiating genetic lesion in sporadically occurring cancers is impossible to identify. The existence 
of rare inherited cancer syndromes has helped to uncover some of the mutations that can initiate 
tumorigenesis. Most of these initiating lesions affect genes belonging to morphogenetic signaling 
pathways. We review the evidence that the cellular fate of individual epithelial cells in the adult 
is nonautonomous and depends on extrinsic information, just like cells in a developing embryo. 
Cancer stem cells need to disrupt these extrinsic restraints to gain an autonomous clonal prolifera-
tive advantage over neighboring stem cells.Multicellular organisms are built from subsets of special-
ized cell types that are allocated to different organs in a 
predefined location and quantity. To develop and main-
tain such a level of complexity, individual cells are subject 
to stringent conditions that determine when and where 
they live and what they do (i.e., cell fate). It is therefore a 
hallmark of cells in multicellular organisms that cell fate is 
not regulated at the level of the individual cell but at the 
population level by extracellular signals. As a result, it is 
not surprising that mutations that disturb this type of inter-
cellular signaling have now been established as important 
initiators of the genetic cancer cascade in epithelial tis-
sues. Our current understanding of the histogenesis of a 
colon carcinoma suggests that this process starts with a 
genetically mutated cancer stem cell that gains a compet-
itive advantage in proliferative capacity over neighboring 
stem cells. To understand how a colonic stem cell is able 
to gain such a competitive advantage, it is first important 
to recognize that cellular fate is controlled by environmen-
tal cues in the intestine.
Evidence for Position-Dependent Cell Fate in the 
Adult
The fate of a cell in a developing embryo is determined 
by its position. The mechanisms used to communicate 
positional information during development have been the 
subject of experimental biology for more than a century 
(Wolpert, 1996). It is much less appreciated that there is 
important evidence for a similar mechanism of cell-fate 
regulation in the adult, especially in rapidly dividing tis-
sues. Similar to that of cells in a developing organ, the 
cellular fate of epithelial cells in the adult gut is regu-
lated by extrinsic signals (extracellular information that 
is nonautonomous to the cell). This information patterns 
epithelial-cell fate along two important axes that are 
addressed separately below.The Vertical Axis
Each stem cell in the gastrointestinal tract generates a 
variety of more committed precursor cells that undergo 
a transient phase of cellular proliferation. Each descen-
dant of these precursor cells exits the cell cycle, is 
allocated to a specific cell lineage, and undergoes a 
process of maturation into a differentiated epithelial 
cell that lives a short life before it dies. This cycle of 
life and death is a linear process from the stem-cell 
niche toward the compartment of differentiated cells. 
A cell that migrates along this vertical axis has to make 
important decisions regarding its cell-cycle status, lin-
eage commitment, maturation status, and death. In a 
hallmark study by the Gordon laboratory, it was shown 
that the fate of epithelial cells is regulated in a non-
autonomous way (Hermiston et al., 1996). This group 
has made use of the fact that each stem cell along 
the longitudinal axis of the gut produces its offspring 
as monoclonal populations. The authors produced a 
series of chimeric mice in which two fertilized zygotes 
(one wild-type and the other transgenic) or one (trans-
genic) embryonic stem cell and a fertilized zygote are 
fused and the clonal offspring of normal and geneti-
cally engineered cells can be juxtaposed. In one such 
chimeric mouse, the cell-cell adhesion molecule E-cad-
herin was specifically overexpressed in maturing small-
intestinal epithelial cells derived of E-cadherin trans-
genic 129/SV mouse ES cells, whereas cells derived 
from the wild-type C57Bl/6 blastocyst were normal. As 
a result, E-cadherin-overexpressing cells produced by 
transgenic stem cells were migrating side by side with 
normal epithelial cells on a single villus. Overexpres-
sion of E-cadherin considerably slowed migration of 
transgenic cells. Even though the speed of migration 
of transgenic cells was much reduced, their maturation 
status along the vertical axis was completely position Cancer Cell 11, February 2007 ©2007 Elsevier Inc. 109
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ReviewFigure 1. Cell-Fate Specification along 
the Longitudinal Axis Is Determined by a 
Stem-Cell Niche
(A) Bone-marrow-derived stem cells have the 
capability to generate a module of cell types 
that is typical for a given location along the 
longitudinal axis of the gut. This illustrates 
the presence of extrinsic signals from the 
mesenchyme specifying cell fate along the 
longitudinal axis at the level of the stem-cell 
niche. Here these mesenchymal cells are 
schematically depicted as secreting a mix of 
extracellular factors specific for that particu-
lar location along the longitudinal axis.
(B) In areas of metaplasia, cell types are gener-
ated that are not appropriate for that specific 
location along the longitudinal axis. In Barrett’s 
esophagus (B), the esophageal multilayered 
squamous epithelium is replaced by intestinal-
type columnar cell epithelium (note presence of 
goblet cells) in the setting of chronic inflamma-
tion (asterisks indicate inflammatory infiltrate). 
(C) Such a phenotypic switch in cell-type gen-
eration could conceivably be caused by the 
influence of the inflammatory infiltrate on the 
composition of extracellular signals in the stem-
cell niche.dependent and the same as their normal counter parts. 
This experiment nicely demonstrated that the intestinal 
epithelial life cycle is extrinsically regulated.
The Longitudinal Axis
Cell fate is not only coupled to the topography of 
the epithelial life cycle but also dependent on cellu-
lar position along a proximal-to-distal axis of the gut 
tube. Regulation along this second axis ensures that 
precursor cells generate a module of specialized cell 
types that suits that particular region of the gut. Cell-
fate regulation along the longitudinal axis is a topic 
that is less well investigated in the adult, especially 
when compared to our understanding of the regula-
tion along the vertical axis. Two lines of evidence sug-
gest, however, that cell-fate specification along the 
longitudinal axis may require continuous patterning 
by epithelial-cell nonautonomous information similar 
to the vertical axis.
Plasticity of Stem Cells
The ongoing nature of precursor-cell programming 
along the longitudinal axis and its dependence on 
extrinsic factors may be best exemplified by recent 
findings in patients and animals receiving bone-mar-
row transplants. Bone-marrow transplants contain 
stem cells that are able to produce cell lineages spe-
cific for many of the recipient’s tissues. Bone-mar-
row stem cells are able to colonize small-intestinal 
crypts in a clonal manner that is typical for gut stem 
cells and stably populate adjacent villi with cells of all 
intestinal epithelial-cellular lineages that appear histo-
logically normal (Jiang et al., 2002; Rizvi et al., 2006). 
The interpretation of some of the work performed with 
bone-marrow-derived stem cells remains controver-110 Cancer Cell 11, February 2007 ©2007 Elsevier Inc.sial, and it is still debated whether stem-cell recruit-
ment and transdifferentiation really occurs, since 
fusion of recruited bone-marrow-derived stem cells 
with resident stem cells would be an alternative sce-
nario (Marx, 2004; Pauwelyn and Verfaillie, 2006). The 
distinction between fusion and transdifferentiation is 
an important one because a recruited stem cell that 
fuses with a resident stem cell would acquire informa-
tion that is intrinsic to the resident stem cell, a scenario 
that does not support a nonautonomous control of pat-
terning along the longitudinal axis (although it would 
not necessarily argue against it). In recent experiments 
in irradiated mice, most of the bone-marrow-derived 
stem cells that contributed to intestinal epithelial tis-
sue seemed to do so through fusion with resident stem 
cells (Rizvi et al., 2006). However, in a study by Hough-
ton et al. (2004) in the Helicobacter-infected stomach, 
it was shown that when female mice were transplanted 
with green fluorescent protein (GFP)-expressing male 
bone-marrow donor cells the donor-derived epithelial 
cells (GFP-positive, negative for hematopoietic marker 
CD45, positive for epithelial marker cytokeratin) con-
tained single X and Y chromosomes, indicating that 
they truly transdifferentiated without cell fusion upon 
recruitment. The fact that such recruitment and trans-
differentiation can occur (however rare it may be) is a 
proof of principle and a strong argument per se in favor 
of the existence of a stem-cell niche in adult epithelial 
tissues. It would mean that the niche contains signals 
that are nonautonomous to the stem cell and inform 
and guide the recruited stem cell to ensure the gen-
eration of the appropriate cell lineage depending on its 
position along the longitudinal axis (Figure 1A). More 
evidence is needed to further clarify this notion.
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The second example of the dynamic nature of precursor-
cell programming along the longitudinal axis is the exis-
tence of metaplasias (Slack, 1986; Tosh and Slack, 2002). 
Epithelium in areas of inflammation can change into a 
phenotype that is inappropriate for the location along the 
longitudinal axis. Such change is known as metaplasia 
and is easily recognized histologically by the presence of 
a cell population that is not normally present in the original 
tissue (e.g., intestinal goblet cells in Barrett’s esophagus; 
Figure 1). Examples in the gastrointestinal tract include 
epithelial columnar cell and/or intestinal metaplasia of the 
esophagus in Barrett’s esophagus (Figures 1B and 1C), 
intestinal metaplasia and pancreatic metaplasia of the 
stomach in atrophic gastritis, gastric mucin cell metapla-
sia of the duodenum in peptic duodenitis, pseudopyloric 
metaplasia of the small intestine in Crohn’s disease, and 
Paneth cell metaplasia of the colon in inflammatory bowel 
disease. It has been suggested that metaplasias might 
result from somatic DNA mutations. However, a monoclo-
nal proliferation of metaplastic cells would be expected 
if metaplasia were due to a somatic mutation and meta-
plasias were multifocal lesions (Thompson et al., 1983) 
that were polyclonal in nature (Nomura et al., 1998). An 
epigenetic mechanism for the development of metapla-
Figure 2. The French Flag Model Applied to Cell-Fate Regu-
lation in the Colonic Crypt
When a morphogen is produced at one end of the crypt, for example, 
by the mesenchymal cells around the crypt base, as depicted sche-
matically in (A), a concentration gradient will form along the axis of 
renewal (B). The French flag model (Wolpert, 1996) is used to depict 
the concentration-dependent mechanism of action of a morphogen. 
In this model, a morphogen can cause three distinct responses in its 
target cells, each at its own threshold concentration. The different re-
sponses are indicated in three different colors: blue, white, and red 
(C). In this way the phenotype of a cell is determined by its precise 
position in this morphogen concentration gradient, and in this model, 
therefore, by its distance from the base of the crypt (D).sias is therefore more likely. We would hypothesize that 
differentiation of gut precursor cells is most likely deter-
mined by extracellular signals that are altered in the above 
situations of inflammation due to factors that alter the 
microenvironment of the precursor-cell niche (Figure 1C). 
Thus, substantial evidence indicates that extrinsic sig-
nals generate the spatial information that is necessary for 
the generation of the appropriate cell-type repertoire by 
stem cells along the longitudinal axis and the subsequent 
maturation and cell death of their descendants along the 
axis of renewal.
Extrinsic Regulators of Cell Fate
Since cellular renewal in the adult gut is regulated by 
extrinsic information (information that is nonautonomous 
to the individual epithelial cell) along two different axes, 
it has important similarities with patterning events in the 
developing embryo. A small number of evolutionarily 
conserved signaling pathways have emerged in devel-
opmental biology as the master regulators of position-
dependent cell fate. Most of these master regulators are 
morphogens, molecules that act by forming concentra-
tion gradients through a tissue (Figure 2) (Lawrence and 
Struhl, 1996). Although most morphogens are proteins, 
this does not mean that concentration gradients neces-
sarily arise by passive diffusion. In fact, proteins of the 
Hedgehog and WNT families of morphogens are lipid 
modified and very poorly soluble (Eaton, 2006). Many 
different levels of active regulation of gradient formation 
probably exist, depending on the morphogen, organ-
ism, and tissue (Torroja et al., 2005; Vincent and Dubois, 
2002; Zhu and Scott, 2004). Morphogens have a con-
centration-dependent effect on their target cells; as a 
result, the distance of the target cell from the source of 
the morphogen determines its phenotype. The WNT, 
Hedgehog (Hh), tumor growth factor-β (TGF-β), and sev-
eral receptor tyrosine kinase families are distinct mor-
phogenetic pathways that have been conserved from 
fruit fly to man. This protein family shares a highly similar 
intracellular tyrosine kinase signaling pathway through 
the RAS-RAF-Mitogen-Activated Protein Kinase and 
PI3 kinase-AKT signaling pathways (Eswarakumar et 
al., 2005; Schlessinger, 2000). The family includes the 
fibroblast growth factor (FGF), epidermal growth factor 
(EGF), platelet-derived growth factor (PDGF), and vas-
cular endothelial growth factor (VEGF) tyrosine kinase 
receptors. Receptor tyrosine kinases share a common 
signaling pathway and are perhaps better known to many 
as growth factors in the adult organism, but all families 
listed above also have important roles as morphogens 
during development (Bottcher and Niehrs, 2005; Coultas 
et al., 2005; Hoch and Soriano, 2003; Shilo, 2005). The 
members of this small number of protein families act in 
varying constellations to form what has previously been 
termed a “morphogenetic code” (Hogan, 1999). The 
morphogenetic code encodes information that enables 
communicating groups of signaling centers to execute 
basic programs such as the formation of a field of pro-Cancer Cell 11, February 2007 ©2007 Elsevier Inc. 111
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we still have limited information on the role of morpho-
gens in the maintenance of homeostasis in the normal 
adult colonic epithelium, the first examples of the role of 
such molecules are slowly starting to emerge.
For example, transcriptional activity of WNT-β-catenin 
signaling acts to maintain a precursor-cell phenotype in 
intestinal epithelial cells (Gregorieff and Clevers, 2005; 
van de Wetering et al., 2002). As colonic epithelial cells 
move up the crypt toward the luminal surface, they start 
to produce the Hh family member Indian Hedgehog, 
which regulates their differentiation (van den Brink et al., 
2004). Members of the TGFβ family regulate colonic epi-
thelial apoptosis in vivo (Dunker et al., 2002; Hardwick et 
al., 2004). Of the FGF family, Keratinocyte Growth fac-
tor (KGF/FGF-7) is expressed by myofibroblast-like cells 
that underlie the colonic enterocytes, and its receptor 
(a splice variant of FGFR2) is expressed on epithelial 
cells (Finch et al., 1996). KGF acts as a positive regu-
lator of precursor-cell proliferation and the goblet cell 
lineage (Housley et al., 1994). The EGF family members 
transforming growth factor-α and Amphiregulin are 
expressed in superficial colonic enterocytes (Johnson 
et al., 1992; Thomas et al., 1992) and probably act in a 
paracrine manner to stimulate colonic epithelial precur-
sor-cell proliferation (Park et al., 1997). The importance 
of these morphogenetic pathways in the maintenance of 
epithelial homeostasis is underscored by the accumu-
lating evidence that mutations that disrupt them are the 
foremost initiators of the genetic cancer cascade identi-
fied to date.
Initiators of Cancer Development
Although a massive research effort has identified many 
genes that are mutated in cancer development, we only 
know relatively few mutations that initiate this process. 
Some groups have been able to identify a few of these 
cancer initiators through the study of families with rare 
inherited cancer syndromes. Generally, affected mem-
bers of these families are heterozygous for the inherited 
mutated gene and develop cancer from a stem cell that 
is affected by a somatic mutation in the remaining wild-
type allele. Many of the inherited mutations in cancer 
syndromes have now been identified. Some of these 
mutations affect stability genes, such as mutations in 
DNA mismatch repair genes that have been found in 
hereditary nonpolyposis colorectal cancer (HNPCC) 
(Chung and Rustgi, 1995; Vogelstein and Kinzler, 2004). 
However, a second class of initiating mutations that has 
emerged from these families involves mutations in path-
ways that form part of the morphogenetic code. Muta-
tions in at least three distinct morphogenetic signaling 
pathways cause gastrointestinal polyposis syndromes. 
First, mutations in the adenomatous polyposis coli (APC) 
gene, a critical component of the WNT pathway that acts 
to restrict its activity cause familial adenomatous pol-
yposis (FAP) syndrome (Kinzler et al., 1991; Nishisho et 
al., 1991). Second, mutations that disrupt expression of 112 Cancer Cell 11, February 2007 ©2007 Elsevier Inc.the BMP receptor 1A and TGFβ family signaling media-
tors SMAD4 and endoglin have been found in juvenile 
polyposis syndrome (JPS) (Howe et al., 1998, 2001; 
Sweet et al., 2005). Although both SMAD4 and Endog-
lin are shared by the TGFβ and BMP signaling pathway, 
this does not mean that disruption of TGFβ signaling per 
se can initiate colorectal carcinogenesis. In mice with 
conditional inactivation of the TGFβ receptor type II (a 
mutation often found in microsatellite unstable colon 
cancers), no histological abnormalities were found in 
the colon, the mice had a rate of colonic epithelial pro-
liferation that was comparable to controls, and no spon-
taneous polyposis developed (Biswas et al., 2004). The 
authors showed in the same paper that the conditional 
TGFβ RII mutation did substantially enhance mutagen-
induced carcinogenesis, more consistent with a role for 
TGFβ pathway mutations in tumor progression. Interest-
ingly it was recently shown in mice that specific abla-
tion of Smad4 expression in T cells resulted in a JPS 
phenotype, whereas disruption of Smad4 expression 
from epithelial cells did not (Kim et al., 2006). This could 
represent an important example of the importance of 
the stroma in epithelial cancer initiation. However, the 
promoters that were used to drive the epithelial-specific 
expression of the Cre transgene and a dominant-nega-
tive form of Smad4 are poorly characterized with regard 
to their use in the intestinal epithelium, and it is not cer-
tain that they target intestinal epithelial stem cells, so 
these results await further confirmation.
The third example is that mutations that affect recep-
tor tyrosine kinase signaling pathways have been found 
in inherited polyposis syndromes. Mutations in PTEN, a 
phosphatase that antagonizes PI3 kinase activity, cause 
Cowden’s syndrome, a syndrome with hamartomas in 
the gastrointestinal tract, central nervous system, and 
skin, and tumors of the breast and thyroid gland (Liaw 
et al., 1997; Marsh et al., 1998). The function of LKB1, 
the gene mutated in Peutz-Jeghers syndrome (Hem-
minki et al., 1998), another important gastrointestinal 
polyposis syndrome, was recently potentially linked to 
the PI3 kinase pathway when it was shown that it acts 
to negatively regulate mammalian target of rapamycin 
(mTOR), a downstream effector of PI3 kinase-AKT sig-
naling (Corradetti et al., 2004; Shaw et al., 2004). No 
germline mutations have been identified in the RAS-
RAF-MAPK pathway, the other major pathway that is 
associated with receptor tyrosine kinase signaling. 
Mutations in both RAS and RAF are found in very early 
lesions however (Alrawi et al., 2006; Beach et al., 2005; 
Goldstein, 2006; Takayama et al., 2001; Yamashita et al., 
1995), and evidence in mice supports the concept that 
RAS mutations can initiate tumorigenesis (Janssen et 
al., 2002). It is important to note that, although receptor 
tyrosine kinases are the classical activators of the RAS-
RAF-MAPK and PI3 kinase pathways, they can also be 
activated by other extracellular signals.
Although all of these syndromes are rare diseases, 
they represent at the same time some of the rare cases 
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ReviewFigure 3. Small Adenomas Expand by 
Crypt Fission
Small adenomas expand by crypt fission. (A) 
Epithelial migration in normal crypts is in a 
straight line from the precursor-cell compart-
ment toward the luminal surface of the gut. (B) 
A microadenoma consisting of two crypts that 
are both in the process of fissioning. The two 
different crypt bases are still in conjunction 
with a single crypt lumen at the top. Normal 
epithelium consists of a polarized monolayer 
of well-differentiated cells (C), whereas the 
epithelium of the microadenoma (D) shows 
crowding of the cells with enlarged hyperchro-
matic nuclei. 
(E–G) Histology of a larger adenomatous polyp 
from a patient with familial adenomatous pol-
yposis. This classical adenoma is a mucosal 
lesion consisting of hyperproliferative dysplas-
tic epithelium that grows as a protruding mass 
into the lumen of the colon (E). The superfi-
cial epithelium of the adenoma (G) shows the 
typical features of dysplasia, such as cellular 
crowding and loss of epithelial polarity, where-
as the adjacent normal epithelium is a highly 
polarized monolayer (F).where certainty exists concerning the nature of the ini-
tiating mutation in the cancer. The importance of these 
mutations is underscored by the fact that these pathways 
are also mutated in sporadically occurring cases of the 
same cancers (Konishi et al., 1996; Luchtenborg et al., 
2004). Even in cancers that are initiated by mutations in 
stability genes, the subsequent mutations in morphoge-
netic pathways might actually initiate neoplastic change 
by allowing clonal stem-cell growth. For example, Miyaki 
et al. found that WNT pathway-activating mutations are 
found in at least 65% of colorectal tumors of patients 
with HNPCC (Miyaki et al., 1999). In contrast to most 
oncogenes and tumor suppressor and stability genes, 
morphogens are not intrinsic signaling molecules, and 
they regulate not just one aspect of cell fate. Morpho-
gens and the components of their intracellular signaling 
pathways (such as APC, β-catenin, SMAD4, PTEN, and 
RAS) are molecules involved in intercellular communica-
tion, and they couple many aspects of cell fate to the 
appropriate cellular position. We will therefore use the 
term morphostats in this review for morphogens and 
the components of their intracellular signal transduc-
tion networks with a role in tissue homeostasis in the 
adult. Of course, we realize that there is no strict division 
between molecules involved in intrinsic cellular signaling 
and those with a role in extrinsic signaling, and such a 
division is a simplification of biological reality. We feel, 
however, that such simplification can sometimes help 
to clarify concepts and advance our understanding of 
biology.
The concept of morphostasis holds that some of 
the factors that pattern a developing organism may be 
equally important in the maintenance of tissue homeo-
stasis (morphostasis) after birth and thus be impor-tant to prevent carcinogenesis. This concept was first 
advanced by Tarin (1972) and later further explored by 
Potter (2001), who introduced the term morphostat. One 
of the hallmarks of the development of colorectal can-
cer is that these morphostats are compromised because 
cell-fate determination is deregulated along the longitu-
dinal axis as well as the axis of renewal at the earliest 
recognizable stages of colorectal carcinogenesis.
Adenoma to Carcinoma Sequence
It is now firmly established that most, if not all, colon car-
cinomas develop from a preceding noninvasive adenoma 
(glandular tumor; Figure 3) (Winawer et al., 1993). Adeno-
mas are neoplasms that are defined by an expansion of 
the proliferating compartment and a lack of differentiation 
of epithelial cells that migrate toward the luminal surface 
of the crypts (dysplasia; Figure 3). Thus, the strict cor-
relation between cellular phenotype and position along 
the vertical axis is disrupted in the adenoma. Substantial 
evidence exists to show that cell fate along the longitu-
dinal axis of the gut is also disturbed in adenomatous 
polyps, as expression of a variety of markers of gastric 
epithelial differentiation has been described in colonic 
adenomatous polyps and colorectal carcinomas (Bara et 
al., 2003; Bartman et al., 1999; Kim et al., 2005; Koike et 
al., 2003; Smith and Watson, 2000). The earliest recog-
nizable adenomatous lesion is the single-crypt adenoma, 
or dysplastic aberrant crypt focus (Nakamura and Kino, 
1984; Preston et al., 2003; Takayama et al., 1998; Wright 
and Poulsom, 2002). The cells that form a single-crypt 
adenoma represent all the appropriate colonic epithelial-
cell lineages and are of monoclonal origin, indicating that 
they originate from a single mutated cancer stem or pre-
cursor cell (Preston et al., 2003). Single-crypt adenomas Cancer Cell 11, February 2007 ©2007 Elsevier Inc. 113
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ReviewFigure 4. Mutations in APC Lead to Deregulated Positional 
Signaling along the Axis of Renewal in the Colonic Crypt
(A) WNT signaling determines a precursor-cell or stem-cell pheno-
type. APC plays an important role in the inhibition of WNT activity as 
cells migrate upwards away from the precursor- or stem-cell niche. 
(B) A model of WNT-regulated positional signaling in a normal 
colonic crypt. Note that this model is adapted from the classical 
model of morphogen signaling by Wolpert (1996) and a gross sim-
plification of the reality in the colonic crypt. In reality, WNTs are 
lipid-modified molecules that are not freely diffusible, and multiple 
WNTs are expressed in both the epithelium and the mesenchyme 
of the colon. This model is based on the level of activity of the 
canonical WNT signaling pathway that can be estimated from the 
nuclear detection of β-catenin and expression of established WNT 
target genes. WNT (blue dots) is secreted in the precursor-cell 
niche; it forms a concentration gradient along the axis of renewal 
and has one or more threshold concentrations for colonic epithelial 
cells specifying different cell fate. At the highest threshold, WNT 
signaling specifies precursor-cell fate (blue cells). Functional APC 
is important for the interpretation of the threshold(s) and acts to 
diminish/shut down WNT signaling when a cell has traveled far 
enough from the precursor-cell niche to arrive at the first threshold 
concentration. 
(C) If APC is mutated, cells are unable to shut down WNT signaling 
upon migration toward the level of the first threshold concentra-
tion, and they will therefore misinterpret the WNT gradient along 
the axis of renewal. As a result, these cells still perceive a level of 
WNT signaling that is above the highest threshold and maintain 
their precursor-cell phenotype. In this way, precursor or stem cells 
accumulate in the APC mutant crypt that subsequently expands 
through crypt fission.114 Cancer Cell 11, February 2007 ©2007 Elsevier Inc.initially expand through crypt fission, a process of crypt 
multiplication that occurs through budding and subse-
quent elongation to form two separate crypts (Figure 3) 
(Wasan et al., 1998; Wong et al., 2002). An elegant study 
by Greaves et al. studied colonic stem-cell behavior using 
the prevalence of nononcogenic mutations in the mito-
chondrial genome that result in detectable cytochrome 
c oxidase deficiency. With this method the authors were 
able to show that the progeny of a morphologically normal 
human colonic crypt stem cell that contains an mtDNA 
mutation can expand to occupy a whole crypt, and that 
this crypt then further expands by fission to form a patch 
of cytochrome c oxidase-deficient crypts (Greaves et al., 
2006). These data indicate that crypt fission results from 
a symmetrical stem-cell division in which both daughter 
cells retain their stem-cell characteristics and each stem 
cell forms its own separate crypt. Crypts in the normal 
mucosa rarely show fission (Li et al., 1994). However, 
crypt fission rates are very high during intestinal growth 
and in situations of mucosal damage and repair (Cairnie 
and Millen, 1975; St Clair and Osborne, 1985). Appar-
ently, the normal restraints on symmetrical stem-cell divi-
sion are relieved under circumstances in which the num-
ber of stem cells needs to be augmented or replenished. 
Although the molecular mechanisms that control the rate 
of crypt fission are still poorly defined, it seems that WNT 
signaling is a positive regulator of the rate of crypt fission, 
as crypt fissioning is strongly increased in patients with 
FAP (see below). Just like stem cells in situations of dam-
age and repair, adenomatous crypts seem to escape the 
normal restraints on symmetrical stem-cell division and 
show a high rate of crypt fission. In this way, the mutated 
stem cell in the adenomatous crypt has gained a com-
petitive advantage over other stem cells in the same crypt 
and stem cells in neighboring crypts that allows clonal 
expansion of the adenoma. After the initial growth by 
crypt fission, the developing tumor later also expands by 
overgrowth of the adjacent normal crypts. In these over-
grown crypts, adenomatous cells enter the crypt from 
the top, whereas the normally differentiated progeny of 
the residing nonmutated stem cell at the crypt base fills 
the lower end of the crypt (Preston et al., 2003). Cells in 
some of the larger adenomas progressively lose their dif-
ferentiation and are able to grow through the basement 
membrane into the lamina propria, the intramucosal car-
cinoma stage. Ultimately, these tumors grow through the 
muscular layer that lies underneath the lamina propria 
and become an invasive carcinoma.
Morphostats and Polyp Formation
Mutations in genes of the WNT, TGF-β family, and recep-
tor tyrosine kinase pathways have been identified as 
the germline mutation in inherited polyposis syndromes 
(Howe et al., 1998, 2001; Kinzler et al., 1991; Liaw et al., 
1997; Marsh et al., 1998; Nishisho et al., 1991). Here we 
will focus on the most frequently mutated gene, APC, 
that is mutated in the FAP syndrome (Figure 4) (Kinzler 
et al., 1991; Nishisho et al., 1991). APC is a central reg-
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tion results in decreased breakdown and increased 
nuclear translocation of β-catenin, the effector protein 
of the WNT pathway (Gregorieff and Clevers, 2005). 
Although APC is often classified as a tumor suppressor 
gene, its role extends beyond a role in cell-cycle arrest 
or apoptosis. APC plays a central role in the transduc-
tion of extrinsic WNT signals to the intestinal epithelial 
stem-cell niche. WNT signaling induces a coordinate 
response in the intestinal epithelial transcriptome that 
specifies multiple aspects of precursor-cell fate (van de 
Wetering et al., 2002). For example, WNT signaling is a 
master switch in precursor-cell proliferation and nega-
tively controls the expression of intestinal epithelial 
differentiation markers (van de Wetering et al., 2002). 
Furthermore, WNT signaling regulates precursor-cell 
positioning via the EphB/Ephrin-B receptor-ligand 
system (Batlle et al., 2002). The broad role for APC in 
the regulation of intestinal epithelial-cell fate has been 
made very clear by elegant experiments performed by 
Sansom et al. (2004) The authors showed that condi-
tional deletion of APC resulted in rapid nuclear accumu-
lation of β-catenin and gross disturbance of epithelial 
homeostasis. Acute APC deficiency resulted in expan-
sion of the precursor-cell population by increased pre-
cursor-cell proliferation and abrogation of their migra-
tion along the crypt-villus axis. Cellular positioning was 
deregulated, as proliferation occurred independently 
of cellular position and Paneth cells were distributed 
throughout the expanded crypt-like area, in contrast to 
their normal position at the crypt base. Loss of APC 
altered cell-fate specification with a loss of goblet 
cells, reduced numbers of endocrine cells, and loss of 
expression of epithelial differentiation markers.
From the histopathological model of adenoma growth 
summarized above, it would follow that any initiator of 
the adenoma carcinoma sequence should also dis-
rupt the normal constraints on the rate of crypt fis-
sion. Indeed, crypt fission in the normal mucosa of FAP 
patients (who are heterozygous for the APC mutation) is 
increased 19-fold compared to the rate of crypt fission 
in the mucosa of unaffected control patients (Wasan et 
al., 1998). Increased nuclear localization of β-catenin is 
observed specifically in crypts that are in the process of 
fission (Preston et al., 2003). These data suggest that 
APC acts as a negative regulator of the rate of crypt 
fission by inhibition of the WNT pathway at the level 
of β-catenin. The fact that mutations in β-catenin that 
make β-catenin resistant to proteolytic degradation are 
also found in colorectal cancers and the fact that such 
mutant β-catenin leads to polyposis in mice indicate 
that the results of the APC mutation are mainly due to its 
role in the canonical WNT signaling pathway (Harada et 
al., 1999). Therefore, appropriate inhibition of canonical 
WNT signaling not only acts to restrict the precursor-cell 
compartment to the precursor-cell niche within a single 
colonic crypt but also functions as an important brake 
on lateral stem-cell expansion through crypt fission and in this fashion inhibits clonal cell growth. Given the 
important role of APC in WNT signaling and the correct 
interpretation of extracellular WNT signals, it appears 
to be legitimate to consider APC in the first place as a 
morphostat.
Conclusion
The phenotype of intestinal epithelial cells is patterned 
along two different axes. The same morphogenetic mol-
ecules that specify positional information in a develop-
ing embryo specify cell fate along the vertical axis in the 
adult, and these may also specify cell fate along the lon-
gitudinal axis, although this is still less well established. 
The link between position and function of epithelial cells 
in a crypt is disrupted at the earliest recognizable stage 
of colorectal carcinogenesis. This corresponds with the 
finding that mutations that are capable of initiating clonal 
cell growth in the colon such as those in APC are muta-
tions in morphogenetic pathways that compromise posi-
tion-dependent regulation of multiple aspects of cellular 
fate. Since morphogenetic pathways are responsible 
for the maintenance of the stability and balance of the 
mucosal microarchitecture in the adult, the term “mor-
phostats” might aptly categorize these genes, in analogy 
with their role as morphogens during development.
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